BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21239399)

  • 1. Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
    Feng F; Xiang Y; Wan X; Geng S; Wang T
    Ann Oncol; 2011 Jul; 22(7):1588-1594. PubMed ID: 21239399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy regimen with floxuridine, dactinomycin, etoposide, and vincristine as primary treatment for gestational trophoblastic neoplasia.
    Wang T; Feng FZ; Xiang Y; Wan XR; Ren T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Jun; 36(3):300-4. PubMed ID: 24997824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary treatment of stage IV gestational trophoblastic neoplasia with floxuridine, dactinomycin, etoposide and vincristine (FAEV): A report based on our 10-year clinical experiences.
    Yang J; Xiang Y; Wan X; Feng F; Ren T
    Gynecol Oncol; 2016 Oct; 143(1):68-72. PubMed ID: 27426306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
    Li Y; Kong Y; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
    Oncologist; 2021 Dec; 26(12):e2209-e2216. PubMed ID: 34396643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia].
    Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital.
    Xiao C; Yang J; Zhao J; Ren T; Feng F; Wan X; Xiang Y
    BMC Cancer; 2015 Apr; 15():318. PubMed ID: 25927660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia.
    Ji M; Jiang S; Zhao J; Wan X; Feng F; Ren T; Yang J; Xiang Y
    Br J Cancer; 2022 Aug; 127(3):524-530. PubMed ID: 35459802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
    Mao Y; Wan X; Lv W; Xie X
    Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
    Zhou Y; Feng FZ; Xiang Y; Wan XR
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE).
    Wang J; Short D; Sebire NJ; Lindsay I; Newlands ES; Schmid P; Savage PM; Seckl MJ
    Ann Oncol; 2008 Sep; 19(9):1578-83. PubMed ID: 18453518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study.
    Kong Y; Yang J; Jiang F; Zhao J; Ren T; Li J; Wang X; Feng F; Wan X; Xiang Y
    Gynecol Oncol; 2017 Jul; 146(1):81-86. PubMed ID: 28461032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
    Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of FAEV regimen in treatment of high-risk drug-resistant gestational trophoblastic tumor].
    Wan XR; Xiang Y; Yang XY; Wu Y; Liu N; Chen L; Dong RF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):88-90. PubMed ID: 16640854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor.
    Wan X; Xiang Y; Yang X; Wu Y; Liu N; Chen L; Dong R
    J Reprod Med; 2007 Oct; 52(10):941-4. PubMed ID: 17977170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia.
    Chu MM; Ma Y; Tse KY; Chan KK; Ngan HY
    Int J Gynecol Cancer; 2015 Mar; 25(3):498-503. PubMed ID: 25628108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
    Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
    Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.